Tapentadol is partially metabolized with the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with prescription drugs that boost or repress the exercise/expression of one or more of those enzymes, and with substrates of these enzymes (as a consequence of Opposition for that enzyme); some enzyme mediators/substrates https://ramseyv021edb2.ttblogs.com/profile